TABLE 4.
Region | Gene | LBFa | Pb | Supporting SNPc | PGWASd | PeQTLe |
Known region | ||||||
1q22 | THBS3 | 7.31 | 2.45 × 10–5 | rs2049805 | 2.82 × 10–8 | 1.85 × 10–9 |
10q23.33 | NOC3L | 7.18 | 2.45 × 10–5 | rs12220125 | 2.09 × 10–9 | 2.79 × 10–9 |
1q22 | GBA | 6.87 | 3.43 × 10–5 | rs12034326 | 1.38 × 10–5 | 2.90 × 10–6 |
Unknown region | ||||||
8q22.2 | FBXO43 | 5.79 | 9.31 × 10–5 | rs2453641 | 9.39 × 10–5 | 3.45 × 10–6 |
7p22.1 | DAGLB | 5.60 | 1.32 × 10–4 | rs4724806 | 1.08 × 10–5 | 3.44 × 10–18 |
19p13.11 | HAPLN4 | 4.18 | 7.99 × 10–4 | rs2905421 | 4.48 × 10–5 | 4.62 × 10–8 |
19q13.43 | ZNF329 | 4.17 | 8.08 × 10–4 | rs157375 | 3.34 × 10–4 | 4.53 × 10–6 |
aLBF (logarithm of Bayes factor) is to assess whether a gene is associated with GC through integrating the GWAS signal and eQTL. The larger LBF score represents the higher probability that the gene is associated with GC. For example, a LBF of 7.31 means that a gene is more likely [1495 times, (exp(7.31) = 1495] to be associated with GC than no association. bP-value from Sherlock integrative analysis. ceSNP with the highest LBF. dP-value from expression quantitative trait analysis. eP-value from meta-analysis of three GC GWAS datasets.